Additionally, rISM1 is reported to inhibit vascular endothelial growth factor (VEGF)-mediated angiogenesis, while overexpression of ISM1 suppressed tumour angiogenesis in B16 melanoma cells and tumour growth in mice [49]. Here, VEGFA is linked to melanoma.